Cas:57957-24-1 N-(1-phenylethenyl)acetamide manufacturer & supplier

Chemical Name:N-(1-phenylethenyl)acetamide

CAS.NO:57957-24-1

Synonyms:N-acetyl-1-phenylethenamine

Molecular Formula:C₁₀H₁₁NO

Molecular Weight:161.20000

HS Code:

Physical and Chemical Properties:

Melting point:91-92ºC

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:32.59000

Exact Mass:161.08400

LogP:2.63370

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-acetyl-1-phenylethenamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-acetyl-1-phenylethenamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-acetyl-1-phenylethenamine Use and application,N-acetyl-1-phenylethenamine technical grade,usp/ep/jp grade.

Related News: A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. N-(1-phenylethenyl)acetamide manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. N-(1-phenylethenyl)acetamide supplier Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. N-(1-phenylethenyl)acetamide vendor A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. N-(1-phenylethenyl)acetamide factory With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.